What
prior research or whose prior work helped to start you on your way?
Cloning of Bcl-2 gene by Carlo Croce, with whom I did post-doc.
Which
of your professional achievements brings you the most satisfaction?
Contributing a new drug for cancer (genasense)...well, almost.
Still in phase III trials.
What
impact might your work and research advances in your field have on the
general public?
New therapies for disease.
Did
you expect your work to become highly cited, or is this surprising to
you?
Didn't think much about it.
What
lessons would you draw from your work to pass on to the next
generation of researchers?
Work hard! Work hard! Work hard! ...and dream big.
If
you had the power to make a single, sweeping change in the way that
scientific research is conducted and presented, what would it be?
More building of collaborative teams of scientists, that merge
complementary talents and focus those talents on a problem or
question of common interest.
n
the Special Topics survey of apoptosis research over the past
decade, the #1 scientist is Dr. John Reed, President and CEO
of the Burnham Institute, with 276 papers cited a total of
16,928 times. Dr. Reed is also the author of the papers ranked
at #19 and #23 in our analysis. In the 
Web product, Dr. Reed’s record shows an excess of 400 papers
cited more than 34,000 times total to date in the field of
Clinical Medicine, Molecular Biology & Genetics, Biology
& Biochemistry, and Immunology. Dr. Reed participated in a
lengthy 
